Mark Sullivan's most recent trade in Mind Medicine Inc was a trade of 11,491 Common Shares done at an average price of $6.8 . Disclosure was reported to the exchange on June 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mind Medicine Inc | Mark R. Sullivan | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 6.80 per share. | 25 Jun 2025 | 11,491 | 305,130 | - | 6.8 | 78,139 | Common Shares |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 27,050 | 27,050 | - | - | Restricted Stock Units | |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2025 | 54,195 | 0 | - | - | Restricted Stock Units | |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2025 | 54,195 | 181,615 | - | 0 | Class A Common Stock | |
| Saul Centers, Inc. | Mark Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 2,000 | 8,400 (0%) | 0% | 0 | Common Stock | |
| Mind Medicine Inc | Mark R. Sullivan | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 6.74 per share. | 25 Mar 2025 | 6,576 | 316,621 | - | 6.7 | 44,322 | Common Shares |
| Mind Medicine Inc | Mark R. Sullivan | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 150,000 | 323,197 | - | 0 | Common Shares | |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 7,575 | 7,575 | - | - | Restricted Stock Units | |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 6,297 | 0 | - | - | Restricted Stock Units | |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 6,297 | 127,420 | - | 0 | Class A Common Stock | |
| Mind Medicine Inc | Sullivan Mark R. | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.43 per share. | 26 Dec 2024 | 4,519 | 173,197 | - | 7.4 | 33,576 | Common Shares |
| Mind Medicine Inc | Mark R. Sullivan | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 5.98 per share. | 25 Sep 2024 | 4,430 | 177,716 | - | 6.0 | 26,491 | Common Shares |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 26,388 | 26,388 | - | - | Restricted Stock Units | |
| Mind Medicine Inc | Mark R. Sullivan | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 25 Jun 2024 | 17,854 | 182,146 | - | 7.2 | 128,906 | Common Shares |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 54,195 | 54,195 | - | - | Restricted Stock Units | |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 25,846 | 0 | - | - | Restricted Stock Units | |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 25,846 | 121,123 | - | 0 | Class A Common Stock | |
| Saul Centers, Inc. | Mark Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 2,000 | 6,400 (0%) | 0% | 0 | Common Stock | |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 6,297 | 6,297 | - | - | Restricted Stock Units | |
| Mind Medicine Inc | Mark R. Sullivan | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Evolv Technologies Holding... | J. Sullivan Mark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 8,012 | 95,277 | - | 0 | Class A Common Stock | |
| Evolv Technologies Holding... | J. Sullivan Mark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 8,012 | 0 | - | - | Restricted Stock Units | |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2023 | 48,494 | 87,265 | - | 0 | Class A Common Stock | |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2023 | 48,494 | 0 | - | - | Restricted Stock Units | |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 25,846 | 25,846 | - | - | Restricted Stock Units | |
| Saul Centers, Inc. | Mark Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 2,500 | 2,500 | - | - | Director Stock Option | |
| Saul Centers, Inc. | Mark Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 200 | 4,400 (0%) | 0% | 0 | Common Shares | |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 8,012 | 8,012 | - | - | Restricted Stock Units | |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 24,271 | 38,771 | - | 0 | Class A Common Stock | |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 24,271 | 0 | - | - | Restricted Stock Units | |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 48,494 | 48,494 | - | - | Restricted Stock Units | |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2022 | 14,500 | 14,500 | - | 0 | Class A Common Stock | |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2022 | 14,500 | 0 | - | - | Restricted Stock Units | |
| Saul Centers, Inc. | Mark Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 2,500 | 2,500 | - | - | Director Stock Option | |
| Saul Centers, Inc. | Mark Sullivan | Director | Grant, award, or other acquisition of securities at price $ 47.90 per share. | 13 May 2022 | 200 | 4,200 (0%) | 0% | 47.9 | 9,580 | Common Shares |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 24,271 | 24,271 | - | - | Restricted Stock Units | |
| Saul Centers, Inc. | Mark Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2021 | 1,500 | 1,000 | - | - | Stock Option | |
| Saul Centers, Inc. | Mark Sullivan | Director | Sale of securities on an exchange or to another person at price $ 52.06 per share. | 21 Dec 2021 | 1,500 | 4,000 (0%) | 0% | 52.1 | 78,090 | Common Shares |
| Saul Centers, Inc. | Mark Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.29 per share. | 21 Dec 2021 | 1,500 | 5,500 (0%) | 0% | 39.3 | 58,935 | Common Shares |
| Saul Centers, Inc. | Mark Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2021 | 1,000 | 0 | - | - | Stock Option | |
| Saul Centers, Inc. | Mark Sullivan | Director | Sale of securities on an exchange or to another person at price $ 52.00 per share. | 21 Dec 2021 | 1,000 | 4,000 (0%) | 0% | 52 | 52,000 | Common Shares |
| Saul Centers, Inc. | Mark Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.29 per share. | 21 Dec 2021 | 1,000 | 5,000 (0%) | 0% | 39.3 | 39,290 | Common Shares |
| Evolv Technologies Holding... | Mark J. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Oct 2021 | 14,500 | 14,500 | - | - | Restricted Stock Units | |
| Saul Centers, Inc. | Mark Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 2,500 | 2,500 | - | - | Director Stock Option | |
| Saul Centers, Inc. | Mark Sullivan | Director | Grant, award, or other acquisition of securities at price $ 43.89 per share. | 07 May 2021 | 200 | 4,000 (0%) | 0% | 43.9 | 8,778 | Common Shares |